Announcements

Trinseo PLC filed a Form 8-K on November 9, 2026, disclosing the issuance of a press release announcing its financial results for the third quarter and year ended September 30, 2026.

Shmuel Barel, Chief Marketing Officer of Wearable Devices Ltd., filed a Form 4 on November 9, 2026, disclosing the acquisition of 20,000 Restricted Share Units on November 5, 2026, at a price of $0 per unit under the company's 2024 Global Equity Incentive Plan.

RB Global, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting condensed consolidated financial results for the three and nine months ended that date.

Turn Therapeutics Inc. filed a Form S-3 registration statement with the SEC on November 9, 2026, covering the potential offering of up to $150,000,000 in aggregate securities and including a separate at-the-market facility of up to $50,000,000 in common stock through TD Securities (USA) …

Superior Group of Companies, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with NASDAQ:SGC on November 9, 2026, reporting third-quarter net sales of $145,994 thousand and nine-month net sales of $434,708 thousand.

Spruce Biosciences, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, disclosing a going concern doubt and a range of material operational risks.

Ocular Therapeutix, Inc. filed a Form S-8 registration statement with the U.S. Securities and Exchange Commission on November 9, 2026, to register an additional 1,000,000 shares of common stock issuable under its 2019 Inducement Stock Incentive Plan, as amended.